Pomalidomide and Dose-Adjusted EPOCH +/- Rituximab for HIV-Associated Lymphomas
Abroad (travel likely)RecruitingPHASE1
Conditions
Diffuse Large Cell Lymphoma · Non-Hodgkin Lymphoma · Burkitt Lymphoma · Plasmablastic Lymphoma · B-Cell Neoplasm
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Contact: Study coordinator (For more information at the NIH Clinical Center contact National Cancer Institute Referral Office) · 888-624-1937
Study leads
Ramya M Ramaswami, M.D.
Principal Investigator
National Cancer Institute (NCI)